Crescent Capital BDC (NASDAQ:CCAP) PT Raised to $19.00

Crescent Capital BDC (NASDAQ:CCAP) had its target price increased by Keefe, Bruyette & Woods from $18.50 to $19.00 in a research note published on Thursday, MarketBeat Ratings reports. The brokerage currently has an outperform rating on the stock.

A number of other research firms have also issued reports on CCAP. Wells Fargo & Company upped their target price on Crescent Capital BDC from $16.50 to $18.00 and gave the company an equal weight rating in a research note on Monday, May 13th. Raymond James upped their price objective on Crescent Capital BDC from $18.00 to $19.00 and gave the company an outperform rating in a research report on Friday, May 10th. Finally, Oppenheimer boosted their target price on shares of Crescent Capital BDC from $18.00 to $19.00 and gave the company an outperform rating in a research note on Friday, February 23rd.

Crescent Capital BDC Stock Performance

Shares of CCAP opened at $17.99 on Thursday. Crescent Capital BDC has a 12-month low of $13.37 and a 12-month high of $18.20. The stock has a market cap of $666.71 million, a P/E ratio of 6.40 and a beta of 0.81. The company has a current ratio of 1.36, a quick ratio of 1.36 and a debt-to-equity ratio of 1.11. The company has a 50-day moving average of $17.43 and a two-hundred day moving average of $17.03.

Crescent Capital BDC Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, July 15th. Stockholders of record on Friday, June 28th will be issued a dividend of $0.42 per share. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.41. The ex-dividend date is Friday, June 28th. This represents a $1.68 annualized dividend and a dividend yield of 9.34%. Crescent Capital BDC’s dividend payout ratio (DPR) is 58.36%.

Hedge Funds Weigh In On Crescent Capital BDC

Several large investors have recently added to or reduced their stakes in CCAP. International Assets Investment Management LLC purchased a new stake in Crescent Capital BDC in the 4th quarter valued at about $1,254,000. Anchor Investment Management LLC purchased a new stake in Crescent Capital BDC in the fourth quarter valued at approximately $342,000. Connor Clark & Lunn Investment Management Ltd. acquired a new position in Crescent Capital BDC during the third quarter worth approximately $240,000. Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Crescent Capital BDC during the fourth quarter worth approximately $843,000. Finally, Virtus ETF Advisers LLC grew its stake in shares of Crescent Capital BDC by 43.5% during the 3rd quarter. Virtus ETF Advisers LLC now owns 40,965 shares of the company’s stock valued at $701,000 after buying an additional 12,420 shares during the period. 49.46% of the stock is currently owned by hedge funds and other institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.